| Effect | Decrease |
| Trial Design | Double blind |
| Trial Length | 1-6 months |
| Number of Subjects | 156 |
| Sex | Both Genders |
| Age Range | 45-64, 65+ |
| Body Types | Overweight, Average |
In persons with osteoarthritis given 100mg pycnogenol once daily for 3 months, supplementation was able to more than half (56% reduction) symptoms of osteoarhritis as assessed by the WOMAC rating scale. An improvement in functional scores and reduction in foot edema was also noted (parameter recorded under leg swelling).
